UK markets closed

Recursion Pharmaceuticals, Inc. (RXRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.42-0.09 (-0.95%)
At close: 04:00PM EDT
9.35 -0.07 (-0.74%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.51
Open9.50
Bid9.39 x 1800
Ask9.44 x 2600
Day's range9.17 - 9.58
52-week range4.97 - 16.75
Volume4,571,767
Avg. volume6,210,771
Market cap2.239B
Beta (5Y monthly)0.85
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

    BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024.SALT LAKE CITY, May 13, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the completion of BioHive-2, Recursion’s new NVIDIA DGX SuperPOD AI supercomputer, powered by 63 DGX H100 systems with a total of 504 NVID

  • GlobeNewswire

    Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results

    On track to read out multiple Phase 2 clinical trials in the coming quarters, beginning in Q3 2024Performance benchmarking completed on BioHive-2, Recursion's next generation supercomputer, which will support the construction of foundation models across biology, chemistry, and patient outcomesTranscriptomics technology has continued to be scaled to more than 1 million transcriptomes with a whole-genome knockout transcriptomics map to be completed in the coming quartersEntered into a multi-year a

  • GlobeNewswire

    Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9

    Company to host public L(earnings) Call on May 9 at 5:00 pm ETSALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide business updates and report its first quarter 2024 financial results on Thursday, May 9, 2024, following the close of the financial markets. Additionally, Recursion will host its quarterly L(earnings) Call on May 9, 2024 at 5:00 pm Eastern